Original Research
Published on 19 May 2022
KRT8 Serves as a Novel Biomarker for LUAD and Promotes Metastasis and EMT via NF-κB Signaling
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.875146
- 3,519 views
- 15 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,601 articles
Articles
Original Research
Published on 19 May 2022
LncRNA-AL035458.2/hsa-miR-181a-5p Axis-Mediated High Expression of NCAPG2 Correlates With Tumor Immune Infiltration and Non-Small Cell Lung Cancer Progression
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.910437
- 4,328 views
- 6 citations
Case Report
Published on 19 May 2022
LMO7-ALK Fusion in a Lung Adenocarcinoma Patient With Crizotinib: A Case Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.841493
- 2,129 views
- 1 citation
Case Report
Published on 18 May 2022
A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the Literature
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.912426
- 2,554 views
- 2 citations
Original Research
Published on 16 May 2022
Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.905871
- 2,759 views
- 4 citations
Original Research
Published on 13 May 2022
Machine Learning for the Prediction of Synchronous Organ-Specific Metastasis in Patients With Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.817372
- 2,668 views
- 3 citations
Original Research
Published on 13 May 2022
Computed Tomography-Based Radiomics for Differentiation of Thymic Epithelial Tumors and Lymphomas in Anterior Mediastinum
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.869982
- 2,176 views
Original Research
Published on 13 May 2022
The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs)
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.874712
- 3,342 views
- 2 citations
Original Research
Published on 11 May 2022
External Application of a Nomogram to Predict Survival and Benefit of Peripheral Blood Inflammatory Indexes in Limited-Stage Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.873367
- 1,490 views
Original Research
Published on 11 May 2022
A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.713476
- 4,585 views
- 10 citations
Brief Research Report
Published on 06 May 2022
Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion?
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.871132
- 8,893 views
- 2 citations
Original Research
Published on 06 May 2022
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.851785
- 3,547 views
- 7 citations
Original Research
Published on 06 May 2022
Obesity Does Not Increase Perioperative Outcomes in Older Patients Undergoing Thoracoscopic Anatomic Lung Cancer Surgery
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.881467
- 1,716 views
- 5 citations
Original Research
Published on 05 May 2022
Immune-Related miRNA-195-5p Inhibits the Progression of Lung Adenocarcinoma by Targeting Polypyrimidine Tract-Binding Protein 1
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.862564
- 2,561 views
- 6 citations
Original Research
Published on 05 May 2022
The Prognostic Impact of Lymph Node Dissection on Primary Tumor Resection for Stage IV Non–Small Cell Lung Cancer: A Population-Based Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.853257
- 2,103 views
- 1 citation
Original Research
Published on 05 May 2022
Survival Benefits for Pulmonary Adenocarcinoma With Malignant Pleural Effusion After Thoracoscopic Surgical Treatment: A Real-World Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.843220
- 3,566 views
- 5 citations